Tests wet-cupping in women with polycystic ovary syndrome
Tests wet-cupping therapy against no cupping in women with polycystic ovary syndrome.
Key facts
- Who runs it
- Princess Nourah Bint Abdulrahman University
- Where
- Riyadh, Saudi ArabiaSee the site
- Trial code
- Registry title
- Effects of Wet-Cupping on Polycystic Ovary Syndrome Patients
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Started
- 1 Jan 2026
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Wet-cupping
- Record updated
- 11 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 20 to 40 with polycystic ovary syndrome (PCOS). It tests whether wet cupping (Hijama) helps their periods and metabolism.
- Age
- 20 to 40 years
- Sex
- Women only
- Disease stage
- Polycystic ovary syndrome (PCOS) diagnosed by the Rotterdam criteria.
- Earlier treatment
- Cannot have used hormonal medicine for periods, herbal period remedies or Metformin in the last month. Cannot have had dry cupping, wet cupping or acupuncture in the past 6 months.
Main reasons for not taking part
- Uncontrolled thyroid problem or diabetes
- Pregnant or breastfeeding
- Known blood clotting disorder
- Anemia with hemoglobin below 10 g/dL
- Other causes of high male hormones, such as Cushing's syndrome or primary ovarian insufficiency
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Female participants
- Aged 20 to 40 years
- Diagnosed with Polycystic Ovary Syndrome (PCOS) according to the Rotterdam criteria
- Willing to participate in the study and provide informed consent
- Not using any of the following in the last month: (Hormonal medications for menstruation, Herbal menstrual remedies or Metformin)
Who cannot take part
- Use of anabolic or androgenic drugs
- Diagnosis of diabetes mellitus
- Known coagulation disorders
- History of undergoing dry cupping, wet cupping, or acupuncture in the past 6 months
- History of surgical removal of both ovaries or the uterus
- Cushing's syndrome
- Hypothalamic or pituitary disorders causing amenorrhea
- Primary ovarian insufficiency
- Hyperprolactinemia with serum levels above 1000 mIU/L
- Anemia with hemoglobin levels less than 10 g/dL
- Known diagnosis of uncontrolled thyroid dysfunction
- Elevated FSH levels above 20 mIU/mL
- Pregnant or lactating women
- Other causes of hyperandrogenism, including:
- Late-onset non-classic 21-hydroxylase deficiency (excluded clinically; lab investigation if clinically indicated)
- Ovarian androgen-secreting tumors
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 40 years old?
Where in Saudi Arabia
- King Abdullah bin Abdulaziz University HospitalRiyadh, Saudi ArabiaContact: Nouran AleyeidiNot yet recruiting
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate whether wet cupping therapy (Hijama) can improve reproductive and metabolic outcomes in women diagnosed with Polycystic Ovary Syndrome (PCOS). This study will be conducted among female participants aged 20-40 years who have been diagnosed with PCOS according to the Rotterdam criteria.
Read full original descriptionShow less
The main questions it aims to answer are:
Can wet cupping therapy regulate menstrual cycles in women with PCOS?
Can it increase the pregnancy rate in married participants with PCOS-related infertility?
Researchers will compare outcomes between a wet cupping group and a control group to determine whether Hijama has significant effects on reproductive, hormonal, and metabolic markers.
Participants will:
Undergo screening and eligibility evaluation using a checklist
Be randomized into either the wet cupping (intervention) or control group
Receive lifestyle counseling (diet and physical activity)
For the intervention group:
Receive one Hijama session performed by a certified practitioner
Undergo follow-up at 4 and 12 weeks for clinical, hormonal, and ultrasound assessments
For all participants:
Complete laboratory tests, ultrasound scans, and questionnaires on PCOS symptoms and quality of life
Report any side effects during and after the study period
The 2 groups in the trial
- Hijama GroupTreatment being tested
Treatment: Wet-cupping
- Control GroupNo study treatment, for comparison
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effects of Wet-Cupping on Polycystic Ovary Syndrome Patients: A Randomized Controlled Trial
- Plain-language title
- Tests wet-cupping in women with polycystic ovary syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07169292, who can take part
- Record updated
- 11 September 2025